| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 11025283 | European Journal of Radiology | 2018 | 21 Pages |
Abstract
Our analysis does not allow the recommendation of dbPET for diagnosis of malignancy in BI-RADS 4 mammographic or US abnormalities, mainly due to its high false-negative rate for the detection of in situ carcinomas (85.7%). However, considering the lesions greater than 0.1âcm and included in the FOV, dbPET depicted all invasive carcinomas.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
L. Graña-López, M. Herranz, I. DomÃnguez-Prado, S. Argibay, A. Villares, A. Ruibal, M. Vázquez-Caruncho,